US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 18.540
  • -0.500-2.63%
Trading Mar 28 10:25 ET
1.11BMarket Cap-2048P/E (TTM)

Sage Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
-21.64%-460.04M
-30.19%-126.93M
-72.70%-118.87M
-3.57%-106.44M
1.18%-107.8M
Net income from continuing operations
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
-17.73%-126.26M
-27.45%-122.06M
Operating gains losses
91.20%-132K
-69.44%-61K
--0
84.15%-42K
97.56%-29K
93.66%-1.5M
99.06%-36K
99.66%-10K
96.43%-265K
87.43%-1.19M
Depreciation and amortization
24.15%1.39M
41.03%409K
18.71%330K
18.64%331K
17.45%323K
-73.17%1.12M
-12.91%290K
-25.67%278K
-68.76%279K
-89.35%275K
Change In working capital
-1,288.22%-67.38M
-1,858.26%-106.29M
954.74%41.69M
719.15%21.22M
-247.07%-24.01M
130.64%5.67M
5.04%6.05M
-84.51%3.95M
112.93%2.59M
76.75%-6.92M
-Change in receivables
-1,531.06%-69.35M
-1,363.49%-60.5M
-240.75%-7.42M
97.76%-88K
-3.95%-1.34M
126.19%4.85M
-15.69%4.79M
-78.25%5.27M
83.42%-3.93M
94.79%-1.29M
-Change in prepaid assets
272.97%19M
31.45%2.88M
200.47%11.62M
394.87%12.53M
-404.52%-8.02M
35.46%-10.99M
139.85%2.19M
-110.33%-11.56M
26.27%-4.25M
1,105.73%2.64M
-Change in payables and accrued expense
-210.06%-14.36M
-5,421.87%-48.48M
258.89%37.43M
3.29%11.63M
-92.56%-14.94M
-29.26%13.05M
-114.42%-878K
45.57%10.43M
15.59%11.26M
-70.66%-7.76M
-Change in other current assets
-15.07%4.3M
2.28%1.61M
30.06%1.83M
-206.39%-1.13M
96.53%1.99M
17.33%5.06M
66.53%1.58M
37.94%1.41M
0.19%1.06M
-21.22%1.01M
-Change in other current liabilities
-10.65%-6.97M
-10.35%-1.8M
-10.34%-1.76M
-10.48%-1.72M
-11.50%-1.69M
-9.76%-6.3M
-11.62%-1.63M
-11.84%-1.6M
-11.62%-1.56M
-4.06%-1.51M
Cash from discontinued investing activities
Operating cash flow
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
-21.64%-460.04M
-30.19%-126.93M
-72.70%-118.87M
-3.57%-106.44M
1.18%-107.8M
Investing cash flow
Cash flow from continuing investing activities
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
132.46%325.43M
396.68%89.78M
544.11%110.95M
146.56%134.26M
98.55%-9.56M
Net PPE purchase and sale
40.98%-553K
139.72%112K
9.89%-328K
8.20%-112K
-33.14%-225K
-151.88%-937K
24.19%-282K
---364K
---122K
---169K
Net investment purchase and sale
35.88%443.47M
-53.42%41.95M
44.38%160.72M
-65.99%45.71M
2,177.88%195.09M
132.57%326.37M
401.31%90.06M
545.57%111.32M
146.60%134.38M
98.57%-9.39M
Cash from discontinued investing activities
Investing cash flow
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
132.46%325.43M
396.68%89.78M
544.11%110.95M
146.56%134.26M
98.55%-9.56M
Financing cash flow
Cash flow from continuing financing activities
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
-76.98%3.07M
117.06%29K
-32.32%1.23M
-99.79%13K
-68.01%1.8M
Proceeds from stock option exercised by employees
122.61%6.93M
--0
122.99%2.77M
2,210.81%855K
83.49%3.3M
-78.85%3.11M
-92.12%33K
-31.50%1.24M
-99.46%37K
-68.01%1.8M
Net other financing activities
-2,000.00%-903K
-6,450.00%-262K
73.33%-4K
---8K
---629K
96.90%-43K
99.32%-4K
---15K
----
----
Cash from discontinued financing activities
Financing cash flow
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
-76.98%3.07M
117.06%29K
-32.32%1.23M
-99.79%13K
-68.01%1.8M
Net cash flow
Beginning cash position
-44.51%163.97M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
-44.51%163.97M
-82.23%295.5M
-52.51%201.1M
-59.69%207.78M
-80.02%179.94M
-82.23%295.5M
Current changes in cash
30.33%-91.65M
-109.34%-77.72M
508.38%27.3M
-405.64%-85.08M
137.95%43.86M
90.38%-131.53M
70.98%-37.13M
92.73%-6.68M
107.23%27.84M
84.84%-115.56M
End cash Position
-55.89%72.32M
-55.89%72.32M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
-44.51%163.97M
-44.51%163.97M
-52.51%201.1M
-59.69%207.78M
-80.02%179.94M
Free cash flow
-17.39%-541.14M
6.14%-119.41M
-14.23%-136.19M
-23.53%-131.63M
-42.55%-153.91M
-21.77%-460.97M
-29.98%-127.21M
-73.23%-119.23M
-3.69%-106.56M
1.02%-107.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M-21.64%-460.04M-30.19%-126.93M-72.70%-118.87M-3.57%-106.44M1.18%-107.8M
Net income from continuing operations -1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M-17.73%-126.26M-27.45%-122.06M
Operating gains losses 91.20%-132K-69.44%-61K--084.15%-42K97.56%-29K93.66%-1.5M99.06%-36K99.66%-10K96.43%-265K87.43%-1.19M
Depreciation and amortization 24.15%1.39M41.03%409K18.71%330K18.64%331K17.45%323K-73.17%1.12M-12.91%290K-25.67%278K-68.76%279K-89.35%275K
Change In working capital -1,288.22%-67.38M-1,858.26%-106.29M954.74%41.69M719.15%21.22M-247.07%-24.01M130.64%5.67M5.04%6.05M-84.51%3.95M112.93%2.59M76.75%-6.92M
-Change in receivables -1,531.06%-69.35M-1,363.49%-60.5M-240.75%-7.42M97.76%-88K-3.95%-1.34M126.19%4.85M-15.69%4.79M-78.25%5.27M83.42%-3.93M94.79%-1.29M
-Change in prepaid assets 272.97%19M31.45%2.88M200.47%11.62M394.87%12.53M-404.52%-8.02M35.46%-10.99M139.85%2.19M-110.33%-11.56M26.27%-4.25M1,105.73%2.64M
-Change in payables and accrued expense -210.06%-14.36M-5,421.87%-48.48M258.89%37.43M3.29%11.63M-92.56%-14.94M-29.26%13.05M-114.42%-878K45.57%10.43M15.59%11.26M-70.66%-7.76M
-Change in other current assets -15.07%4.3M2.28%1.61M30.06%1.83M-206.39%-1.13M96.53%1.99M17.33%5.06M66.53%1.58M37.94%1.41M0.19%1.06M-21.22%1.01M
-Change in other current liabilities -10.65%-6.97M-10.35%-1.8M-10.34%-1.76M-10.48%-1.72M-11.50%-1.69M-9.76%-6.3M-11.62%-1.63M-11.84%-1.6M-11.62%-1.56M-4.06%-1.51M
Cash from discontinued investing activities
Operating cash flow -17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M-21.64%-460.04M-30.19%-126.93M-72.70%-118.87M-3.57%-106.44M1.18%-107.8M
Investing cash flow
Cash flow from continuing investing activities 36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M132.46%325.43M396.68%89.78M544.11%110.95M146.56%134.26M98.55%-9.56M
Net PPE purchase and sale 40.98%-553K139.72%112K9.89%-328K8.20%-112K-33.14%-225K-151.88%-937K24.19%-282K---364K---122K---169K
Net investment purchase and sale 35.88%443.47M-53.42%41.95M44.38%160.72M-65.99%45.71M2,177.88%195.09M132.57%326.37M401.31%90.06M545.57%111.32M146.60%134.38M98.57%-9.39M
Cash from discontinued investing activities
Investing cash flow 36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M132.46%325.43M396.68%89.78M544.11%110.95M146.56%134.26M98.55%-9.56M
Financing cash flow
Cash flow from continuing financing activities 96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M-76.98%3.07M117.06%29K-32.32%1.23M-99.79%13K-68.01%1.8M
Proceeds from stock option exercised by employees 122.61%6.93M--0122.99%2.77M2,210.81%855K83.49%3.3M-78.85%3.11M-92.12%33K-31.50%1.24M-99.46%37K-68.01%1.8M
Net other financing activities -2,000.00%-903K-6,450.00%-262K73.33%-4K---8K---629K96.90%-43K99.32%-4K---15K--------
Cash from discontinued financing activities
Financing cash flow 96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M-76.98%3.07M117.06%29K-32.32%1.23M-99.79%13K-68.01%1.8M
Net cash flow
Beginning cash position -44.51%163.97M-25.39%150.04M-40.92%122.75M15.50%207.83M-44.51%163.97M-82.23%295.5M-52.51%201.1M-59.69%207.78M-80.02%179.94M-82.23%295.5M
Current changes in cash 30.33%-91.65M-109.34%-77.72M508.38%27.3M-405.64%-85.08M137.95%43.86M90.38%-131.53M70.98%-37.13M92.73%-6.68M107.23%27.84M84.84%-115.56M
End cash Position -55.89%72.32M-55.89%72.32M-25.39%150.04M-40.92%122.75M15.50%207.83M-44.51%163.97M-44.51%163.97M-52.51%201.1M-59.69%207.78M-80.02%179.94M
Free cash flow -17.39%-541.14M6.14%-119.41M-14.23%-136.19M-23.53%-131.63M-42.55%-153.91M-21.77%-460.97M-29.98%-127.21M-73.23%-119.23M-3.69%-106.56M1.02%-107.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg